Friday, January 30, 2026

3:00 p.m. – 4:00 p.m. ET

Please note this TeleECHO program is 3:00 p.m. Eastern, 2:00 p.m. Central, 1:00 p.m. Mountain and 12:00 p.m. Pacific.

PRESENTING FACULTY

Ebony R. Hoskins, MD, FACOG Section Director Gynecologic Oncology MedStar Washington Hospital Center Washington, DC

PROGRAM OVERVIEW

This educational activity is designed to address the needs of US-based healthcare professionals involved in the treatment of patients with HER2-positive solid tumors including gynecological, bladder, and biliary tract cancers. The program will enhance participants’ ability to apply clinical guideline recommendations for identifying and diagnosing HER2+ overexpression across multiple cell types; evaluate the clinical efficacy and tolerability profiles for ADCs that target HER2+ overexpression; and summarize patient-centered strategies for communication and education to effectively provide individualized care, including managing adverse events.

TARGET AUDIENCE

This activity is intended for U.S.-based community oncology teams, including oncologists and multidisciplinary healthcare professionals who treat patients with HER2-positive solid tumors. including gynecological, bladder, and biliary tract cancers.

LEARNING OBJECTIVES

Upon completion of this activity, attendees will have improved ability to:

• Apply clinical guideline recommendations for identifying and diagnosing HER2+ overexpression across multiple cell types
• Evaluate the clinical efficacy and tolerability profiles for ADCs that target HER2+ overexpression
• Summarize patient-centered strategies for communication and education to effectively provide individualized care, including managing adverse events

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education (CE) for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this virtually live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the virtually live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 1.0 ANCC contact hour.

ACCME INNOVATION PARTNER

Med Learning Group (MLG) is proud to be recognized as an ACCME Innovation Partner, leading the way in simplifying CME for physicians. As an Innovation Partner, MLG will be working with the ACCME by submitting credits directly to CME Passport.

ACCME INNOVATION PARTNER DISCLAIMER

Upon your acceptance in the evaluation and completion of this CME activity, Med Learning Group will share your completion information and certain personal details (e.g., name, National Provider Identifier, birthdate MM/DD) with the ACCME for inclusion in your CME Passport transcript and, as applicable, reporting to certifying, licensing, or other regulatory authorities you specify.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]